RPS5 is integral to ribosomal assembly and translational initiation:
rRNA Binding: Cross-links to helices H28–H30 and H41–H43 of 18S rRNA, analogous to prokaryotic RPS7-16S rRNA interactions .
Initiation Complex Stabilization: Interacts with initiation factors (eIF3, eEF1A, and eIF2α) to ensure accurate start-codon selection .
Viral Translation: Facilitates internal ribosome entry site (IRES)-mediated translation in hepatitis C virus (HCV) by binding IRES domains II and IV .
Hepatocellular Carcinoma (HCC): RPS5 is upregulated in HCC tissues and cell lines. Knockdown experiments in MHCC97H and HLE cells suppress proliferation, migration, and metastasis .
Colorectal Cancer: Variable expression levels are observed in tumor tissues, though no direct correlation with disease severity has been established .
Hepatic Fibrosis: RPS5 modulates Akt phosphorylation, influencing hepatic stellate cell (HSC) activation. Overexpression reduces fibrosis progression in dimethylnitrosamine (DMN)-induced models .
HCV and RHDV: RPS5 binds viral RNA (e.g., HCV IRES and RHDV 3′ Ex RNA), enhancing viral replication. The β-hairpin fragment (P121–R146) is critical for IRES interaction .
Target for Liver Disease: Fragment P121–R146 is a promising target for inhibiting HCV translation .
Cancer Therapy: Silencing RPS5 reduces tumor growth in orthotopic mouse models, highlighting its viability as an anticancer target .
Formulation: 0.25 mg/mL in 20 mM Tris-HCl (pH 8.0), 0.2 M NaCl, 50% glycerol, and 2 mM DTT .
Stability: Stable at 4°C for 2–4 weeks; long-term storage requires -20°C with carrier proteins (0.1% HSA/BSA) .
Usage Restrictions: Exclusively for laboratory research; not approved for clinical or agricultural use .
Human RPS5 is a 204 amino acid protein that functions as a component of the small ribosomal subunit (40S) . It belongs to the family of ribosomal proteins that includes bacterial rpS7. The protein forms part of the exit (E) site on the small ribosomal subunit and cross-links to the E-site tRNA . RPS5 contributes to the formation of the mRNA exit channel and interacts with other ribosomal proteins such as rpS11, which is located on the platform of the small subunit . This interaction appears to contribute to structural rearrangements of the head of the small subunit during translation . Additionally, RPS5 participates in the small subunit (SSU) processome, which is the first precursor of the small eukaryotic ribosomal subunit . During SSU processome assembly, RPS5 associates with nascent pre-rRNA along with other ribosome biogenesis factors and RNA chaperones to facilitate RNA folding, modifications, rearrangements, and cleavage .
Researchers can utilize several tools to study human RPS5:
Recombinant Proteins: Full-length human RPS5 protein (1-204 aa) expressed in E. coli with >90% purity is commercially available for biochemical studies .
Antibodies: Polyclonal antibodies against RPS5 suitable for Western blot (WB), immunohistochemistry (IHC-P), and immunocytochemistry/immunofluorescence (ICC/IF) techniques are available . These antibodies have been validated to work with human and mouse samples.
Cell Lines: Multiple human cell lines including MCF7, HL-60, HeLa, HepG2, and Jurkat express detectable levels of RPS5 and can be used for functional studies .
Cross-species Models: Yeast models where endogenous rpS5 is replaced with human RPS5 provide valuable functional insights .
Experimental approaches should be selected based on specific research questions, with careful consideration of controls to ensure specificity and reproducibility of results.
RPS5 expression and localization can be assessed through various complementary approaches:
Western Blotting: Using validated anti-RPS5 antibodies, researchers can detect RPS5 protein levels in cell or tissue lysates. This technique has been successfully used across multiple human cell lines including MCF7, HL-60, HeLa, HepG2, and Jurkat .
Immunohistochemistry: For tissue localization studies, paraffin-embedded sections can be probed with anti-RPS5 antibodies to examine expression patterns in different cell types .
Immunofluorescence: This approach provides higher resolution information about subcellular localization of RPS5, particularly its association with nucleolar structures during ribosome biogenesis .
Polysome Profiling: This technique allows assessment of RPS5 association with actively translating ribosomes and can reveal defects in translation or ribosome assembly when RPS5 function is altered .
When conducting these studies, it's important to include appropriate controls and to consider that as a ribosomal protein, RPS5 is generally abundantly expressed in actively proliferating cells.
Human RPS5 plays crucial roles in maintaining translational fidelity through several mechanisms:
Reading Frame Maintenance: Studies using yeast expressing human RPS5 instead of the yeast homolog demonstrated moderate increases in both +1 and -1 programmed frameshifting, indicating that RPS5 helps maintain the correct reading frame during translation .
Stop Codon Recognition: The same cross-species model showed hyperaccurate recognition of the UAA stop codon, suggesting RPS5 involvement in translation termination fidelity .
IRES-Mediated Translation: Human RPS5 appears to influence Internal Ribosome Entry Site (IRES) function, as yeast expressing human RPS5 showed increased activities of the cricket paralysis virus (CrPV) IRES and two mammalian cellular IRESs (CAT-1 and SNAT-2) .
Translation Elongation or Termination: Replacement of yeast rpS5 with human RPS5 resulted in increased heavy polyribosomal components, suggesting either translation elongation or termination defects .
These findings highlight RPS5's multifaceted role in ensuring accurate protein synthesis, though the precise molecular mechanisms remain to be fully elucidated.
Comparative analyses reveal important structural differences between human RPS5 and its homologs:
N-terminal Extension: A key difference is that human RPS5 lacks the negatively charged (pI ~3.27) 21-amino acid long N-terminal extension that is present in fungal homologs . This structural difference has functional consequences for protein synthesis.
Functional Conservation: Despite these differences, human RPS5 can substitute for its yeast homolog in vivo, though with a 20-25% decrease in growth rate, demonstrating functional conservation across species .
Evolutionary Rate: Studies of RPS5 homologs like the Drosophila paralog RpS5b show evidence of positive selection, suggesting adaptive evolution of this protein family . These evolutionary patterns may reflect species-specific optimization of translation machinery.
Interaction Surfaces: The protein regions that interact with other ribosomal components and translation factors appear to be more conserved than other regions, reflecting functional constraints on these interaction interfaces.
These structural differences provide valuable insights into the evolution of translation machinery across eukaryotes and can inform structure-function studies of RPS5.
Cross-species models, particularly yeast expressing human RPS5, offer powerful approaches for studying this protein:
Experimental Approach:
Cloning human RPS5 into a high-copy number vector under a constitutive promoter (such as TEF).
Transforming this construct into a diploid heterozygous yeast strain with one disrupted copy of the RPS5 gene.
Inducing sporulation and performing tetrad dissection to obtain haploid strains where human RPS5 is the sole source of the protein .
Expression Level Considerations: When replacing yeast RPS5 with human RPS5, it's important to ensure balanced expression. In eukaryotic cells, especially yeast, balanced expression of ribosomal proteins is achieved through regulated protein turnover, with excess proteins being rapidly degraded .
Phenotypic Analysis: Researchers can assess growth rates, polysome profiles, translational fidelity (frameshifting, stop codon recognition), and IRES activity to evaluate the functional consequences of human RPS5 expression .
Limitations: Cross-species differences in ribosome-associated factors may influence results, necessitating careful interpretation and validation in human cell systems when possible.
This approach has revealed that human RPS5 can functionally substitute for yeast RPS5, though with alterations in translational properties that provide insights into RPS5 function .
RPS5 serves critical functions in ribosome assembly:
SSU Processome Participation: RPS5 is part of the small subunit (SSU) processome, which is the first precursor of the small eukaryotic ribosomal subunit .
Pre-rRNA Processing: During SSU processome assembly in the nucleolus, RPS5 associates with nascent pre-rRNA along with other ribosome biogenesis factors and RNA chaperones .
Coordinated Activities: These components work together to facilitate RNA folding, modifications, rearrangements, and cleavage, as well as targeted degradation of pre-ribosomal RNA by the RNA exosome .
Structural Integration: RPS5 must be properly incorporated into the nascent ribosome for correct assembly and maturation of the small subunit, ensuring functional ribosome production.
Research into these processes typically employs approaches such as rRNA processing analysis, nucleolar proteomics, and co-immunoprecipitation studies to identify RPS5 interaction partners during various stages of ribosome biogenesis.
While direct links between RPS5 mutations and human diseases remain limited in the literature, several lines of evidence suggest potential disease relevance:
Translational Fidelity: RPS5's role in maintaining translational fidelity suggests that mutations could lead to increased frameshifting or altered termination, potentially resulting in production of aberrant proteins .
Ribosome Biogenesis: As RPS5 participates in ribosome assembly, defects could impair protein synthesis capacity, particularly affecting rapidly dividing cells or tissues with high protein synthesis demands .
Comparative Insights: Studies of other ribosomal proteins have linked mutations to "ribosomopathies" - a class of disorders characterized by defective ribosome biogenesis or function. By analogy, RPS5 alterations might contribute to similar pathologies.
Research Approaches: Investigating potential RPS5-related disease mechanisms would benefit from approaches like:
CRISPR-mediated gene editing to introduce disease-associated variants
Patient-derived cell studies comparing RPS5 expression, localization, and function
Ribosome profiling to assess global translation impacts of RPS5 alterations
Further research is needed to establish direct links between RPS5 dysfunction and specific human diseases, representing an important area for future investigation.
Ribosomal Protein S5 (RPS5) is a crucial component of the 40S subunit of eukaryotic ribosomes. It belongs to a highly conserved family of ribosomal proteins, which play essential roles in the process of translation and protein synthesis. RPS5 is particularly significant due to its involvement in the initiation of translation and its potential implications in various diseases, including cancer and liver disease .
RPS5 is located at the head of the 40S ribosomal subunit and is characterized by its basic nature, containing many arginyl and lysyl residues, with an estimated isoelectric point (pI) of 9.6 . This protein is essential for cell viability and plays a substantial role in the binding of 18S ribosomal RNA (rRNA), which is a critical component of the small ribosomal subunit .
The primary function of RPS5 is to facilitate the assembly of the ribosome and the translation of messenger RNA (mRNA) into proteins. It achieves this by interacting with other ribosomal proteins and rRNA to form a functional ribosome. Additionally, RPS5 has been implicated in non-ribosomal functions, such as the regulation of cell growth and proliferation .
Recent studies have highlighted the potential role of RPS5 in various diseases. For instance, alterations in the expression of RPS5 have been associated with liver disease and certain types of cancer . The protein’s involvement in these conditions is thought to be related to its role in translation initiation and its interactions with other cellular components.
In cancer, RPS5 may contribute to tumorigenesis by affecting the synthesis of proteins that regulate cell growth and division. Similarly, in liver disease, changes in RPS5 expression could impact the production of proteins necessary for liver function and regeneration .
Human recombinant RPS5 is a form of the protein that is produced using recombinant DNA technology. This involves inserting the gene encoding RPS5 into a suitable expression system, such as bacteria or yeast, to produce the protein in large quantities. Recombinant RPS5 is used in various research applications to study its structure, function, and role in diseases.
The availability of human recombinant RPS5 has facilitated numerous studies aimed at understanding the molecular mechanisms underlying its functions and interactions. These studies have provided valuable insights into the protein’s role in translation and its potential as a therapeutic target for diseases .